Pfizer and BioNTech seek FDA emergency use authorization for coronavirus vaccine
5 years ago 1 min read
Pfizer and BioNTech said they will submit to the US Food and Drug Administration today for an emergency use authorization for their coronavirus vaccine candidate.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push